Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe 'golden dose' is the informal name for the 5mg Mounjaro dose — the point where most people begin to notice meaningful appetite reduction. When to take it depends on your titration schedule: your prescriber will typically move you from 2.5mg to 5mg after your first four weeks, once your body has had time to adjust. Mounjaro is a prescription-only medicine, so timing and any changes to your dose are decisions made with a qualified prescriber, not taken independently.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The name isn't official, it comes from patient communities and has spread because so many people report a clear shift in appetite when they reach 5mg. Tirzepatide works by activating two gut-hormone receptors, GIP and GLP-1, which together slow how quickly the stomach empties and raise the feeling of fullness after eating. The Mounjaro overview explains the mechanism in more detail, but the short version is: 2.5mg is there to let your system settle, not to drive weight loss. At 5mg, you're stepping into the range where the medicine's therapeutic effect begins in earnest for most people.
Clinical trial data published in the New England Journal of Medicine (SURMOUNT-1) showed meaningful weight reduction at 5mg and above, with results increasing at higher doses. The 5mg golden dose page sets out what the evidence says about outcomes at this specific strength. Importantly, not everyone's golden dose is 5mg, some people find that appetite suppression kicks in earlier, others need a higher dose before the effect is pronounced. That's a clinical conversation, not a self-assessment.
The phrase has become useful shorthand, but it's worth knowing it has no formal standing in the prescribing guidance. The Mounjaro SmPC describes a structured titration from 2.5mg upward, with each step determined by tolerability and response.
The standard titration schedule, as described in the NHS tirzepatide medicines page, starts at 2.5mg for the first four weeks. That first pen's job is adjustment, giving your digestive system the chance to get used to the medicine before the dose increases. If you've tolerated 2.5mg reasonably well, most prescribers will move you to 5mg at week five.
That four-week point is a clinical checkpoint, not a guaranteed automatic promotion. A prescriber will want to know how you've been getting on: any nausea, vomiting or other gastrointestinal effects, and how pronounced they were. If side effects were significant, staying at 2.5mg for a further four weeks is sometimes the right call. Rushing the step-up rarely helps.
At nume, every dose increase requires a fresh clinical review. A real prescriber reads your update (a question our clinical team fields regularly) before any change is approved. You can read more about when to take your first Mounjaro dose for context on how the titration starts. See also our clinical team's approach to understanding how prescriber oversight works in practice.
Mounjaro is injected once a week, and the day you choose is largely a matter of routine. The main practical rule: keep the same day each week. Many people pick a day that fits around their schedule, some choose Monday so the injection is done before the working week starts, others prefer Sunday evening. If you took your 2.5mg starter dose on a particular day of the week, moving to 5mg on the same day makes the most sense.
Life doesn't always cooperate, of course. The Mounjaro Patient Information Leaflet (available via the guide on how to take the golden dose) covers the permitted window if you need to shift a dose day. As a general principle, the further you push a dose from its scheduled day, the less consistent the medicine's effect. Don't adjust your schedule independently, check the leaflet or speak to your prescriber.
One practical note worth making: if you're ordering before the 12pm cut-off and your usual injection day is the following morning, same-day dispatch means your pen can arrive in time via next-working-day delivery. Worth planning around.
Some people find the jump to 5mg is immediately noticeable, appetite drops, portion sizes feel different, cravings ease. Others don't feel a sharp shift. Both experiences are normal and don't necessarily mean the medicine isn't working; individual responses to tirzepatide vary, as the Mounjaro 5mg page discusses.
If you've been on 5mg for four weeks and feel no meaningful change, that's exactly the kind of thing your prescriber needs to hear. The titration schedule goes up to 15mg, and the evidence across the SURMOUNT programme shows that higher doses generally produce greater average weight loss. A further increase would be reviewed clinically, it's not something to decide on your own. Equally, if side effects at 5mg have been difficult, your prescriber might hold at that dose longer or suggest ways to manage them.
For context on what private Mounjaro treatment involves financially, the Mounjaro pricing page sets out what a transparent cost should cover. If you'd like to explore whether Mounjaro is suitable for you, speak to our prescribers through a free consultation, clinical review is included, with no subscription required.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.